General Announcement::Board Meeting Intimation

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
05-Aug-2020 20:52:40
Status
New
Announcement Sub Title
Board Meeting Intimation
Announcement Reference
SG200805OTHRAIWE
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary Compliance Officer
Effective Date and Time of the event
05/08/2020 00:00:00
Description (Please provide a detailed description of the event in the box below)
We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Friday, August 14, 2020, inter alia, to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2020.

Attachments

SGX_Letter_BBM_05082020.pdf
Total size =395K